Recent Congressional hearings have focused on the following health policy issues, among others:
- A House Ways and Means Health Subcommittee hearing entitled “Physician Organization Efforts to Promote High Quality Care and Implications for Medicare Physician Payment Reform";
- A Senate Commerce, Science and Transportation Committee hearing on short-supply, “gray market” prescription drugs; and
- A House Oversight and Government Reform Committee hearing on the Obama Administration’s Medicare Advantage Quality Bonus Payment Demonstration. The Panel also has scheduled an August 2 hearing on IRS enforcement of the ACA’s tax provisions.